Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
7,803 total articles
Zymeworks Inc. has appointed Adam Schayowitz, Ph.D., MBA as Head of Research & Development and Scott Platshon as Chief Business Officer, promoting both from interim roles. These leadership enhancements come during a pivotal growth phase focused on advancing the company’s diverse biotherapeutics pipeline, integrating partnerships, and expanding lice…
Rezolve Ai PLC publicly responded to Commerce.com's Board rejection of Rezolve's proposed acquisition offer, criticizing Commerce.com's growth outlook and valuing Rezolve's 7.5x year-on-year revenue growth and contracted sales. Rezolve commits to further engagement with Commerce.com shareholders to promote a merger aimed at accelerating liquidity, …
Whitestone REIT announced a definitive merger agreement to be acquired by Ares Management Corporation for $19.00 per share, representing a 12.2% premium to the prior closing price and totaling approximately $1.7 billion. The deal, approved by Whitestone's Board, is expected to close in Q3 2026, and will result in Whitestone becoming a privately hel…
House of Doge, corporate arm of the Dogecoin Foundation, and merger partner Brag House Holdings (NASDAQ: TBH) congratulated HC Sierre on winning the 2025-26 Sky Swiss League Championship, marking the club's first Swiss League title since 1967. As second-largest owner and principal sponsor, House of Doge has integrated Dogecoin branding onto the tea…
707 Cayman Holdings Limited announced a 20-for-1 share consolidation effective April 13, 2026, to comply with Nasdaq Marketplace Rule 5550(a)(2) and maintain its Nasdaq listing. Post-consolidation, the company will have fewer outstanding shares trading under the same ticker symbol JEM with a new CUSIP.
Paramount Gold Nevada Corp. has begun an Initial Assessment under SEC S-K 1300 for its 100%-owned Sleeper Gold Project in Nevada, aiming to evaluate a lower-cost, heap-leach focused development approach concentrating on oxide and mixed mineralization. This assessment may accelerate cash flow generation and enhance the project's economics while supp…
Equinox Gold Corp. delivered a robust first quarter in 2026 with gold production totaling 197,628 ounces, including strong contributions from its Canadian operations. The company successfully reduced debt by $990 million and initiated its inaugural quarterly dividend of $0.015 per share. Operational improvements at Greenstone and Valentine mines ar…
Five Star Bancorp has announced a $10 million Low Income Housing Tax Credit (LIHTC) investment in the Marvel in the Mission development, a 136-unit permanent supportive housing project in San Francisco's Mission District. This marks the bank's first such investment in the Bay Area, supporting affordable housing combined with wraparound services to …
Unicycive Therapeutics, a clinical-stage biotechnology company focused on kidney disease treatments, announced that CEO Shalabh Gupta will present at the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026. The company is developing oxylanthanum carbonate, a novel phosphate binder under FDA review for hyperphosphatemia in dialysis p…
New Era Energy & Digital, Inc. announced pricing for an underwritten public offering of nearly 29.85 million shares at $3.35 each, aiming to raise approximately $100 million gross proceeds. The company plans to use the net proceeds primarily to repay all outstanding borrowings under a senior secured convertible promissory note and for general corpo…
Invivyd announces progress in its Phase 3 pivotal DECLARATION study of VYD2311 for COVID-19 prevention, including a sample size increase to enhance statistical power and a slight delay in expected top-line results to Q3 2026. The company also reveals discovery and rapid development plans for VMS063, a novel, potentially first- and best-in-class mon…
Beyond Meat, Inc. received a Nasdaq notice for late filing of its 2025 Annual Report on Form 10-K but filed the report on April 9, 2026, regaining compliance and avoiding the requirement to submit a Nasdaq compliance plan. The company reaffirms its commitment to plant-based protein products and highlights risks detailed in its Annual Report.
Occidental Petroleum Corporation reported a new oil discovery at the Bandit prospect located about 125 miles south of Louisiana in the Gulf of America. The discovery involves high-quality, full-to-base oil-bearing Miocene sands and offers potential subsea infrastructure tie-backs to existing nearby facilities. Occidental, which operates the site an…
Aurora Mobile Limited, a NASDAQ-listed company, has introduced Modellix.ai, a unified multimodal AI platform that standardizes access to various global elite image and video AI models. Modellix addresses the complexity and fragmentation currently present in the generative AI market by simplifying integration, billing, and management, thereby enhanc…
RYTHM, Inc.'s award-winning THC edibles brand incredibles has introduced Peanut Buddah Cups, a new THC and CBG infused treat combining peanut butter and milk chocolate. This launch bolsters incredibles' position as a market leader in edibles through innovative flavor and dosing, reinforcing its status as the top-selling chocolate edible brand in th…
Nkarta, Inc., a clinical-stage biopharmaceutical company specializing in engineered natural killer (NK) cell therapies for autoimmune diseases, announced its participation in the 25th Annual Needham Virtual Healthcare Conference. Company executives will discuss their investigational CAR-NK cell therapy targeting B cell-mediated autoimmune diseases …
Seres Therapeutics announced its presentation at the 2026 CARB-X Investor Day, underscoring its ongoing collaboration with CARB-X to develop novel live biotherapeutics targeting antimicrobial resistance (AMR). The company highlighted its advancement of SER-428, an oral liquid formulation intended for ICU patients at high risk of AMR infections, sup…
Kymera Therapeutics announced that Gilead Sciences has exercised its option to exclusively license KT-200, a novel oral CDK2 molecular glue degrader developed by Kymera. This triggers a $45 million milestone payment to Kymera, with Gilead advancing the program toward IND-enabling studies for a potential 2027 IND filing. KT-200 offers a targeted the…
Satellos Bioscience Inc., a clinical-stage biotechnology company focused on therapies for degenerative muscle diseases, announced its participation in the Bloom Burton & Co. Healthcare Investor Conference in April 2026. CEO Frank Gleeson will present on the company's progress with its oral small molecule drug SAT-3247 targeting muscle repair in Duc…
Rani Therapeutics, a clinical-stage biotherapeutics company listed on Nasdaq, announced the appointment of Dr. Sara Kenkare-Mitra as Strategic Advisor. Dr. Kenkare-Mitra brings extensive expertise in biologics development and will support the advancement of Rani's oral biologics platform, including their RaniPill technology and programs such as ora…
The Scotts Miracle-Gro Company has finalized the divestiture of its subsidiary, The Hawthorne Gardening Company, to cannabis operator Vireo Growth. The transaction supports ScottsMiracle-Gro's strategy to concentrate on its core lawn and garden products, with no impact on its full fiscal 2026 guidance. The company expects the divestiture to aid mar…
Shoals Technologies Group, a leading manufacturer of electrical infrastructure solutions for solar, battery storage, and data centers, announced it will release its first quarter 2026 earnings on May 5, 2026, before market open, followed by a conference call. The company also highlighted its role in advancing energy transition technologies.
Foghorn Therapeutics announced upcoming presentations of new preclinical data for its selective SMARCA2 inhibitor FHD-909 and other degrader programs targeting CBP, EP300, and ARID1B at the 2026 AACR Annual Meeting. The data suggest potential expansion opportunities for combination therapies in various cancer types, reinforcing the company's innova…
Biodesix has been recognized as a 2026 USA TODAY Top Workplaces award winner for the third consecutive year, a designation based on direct employee feedback regarding workplace experience and culture. The award reflects Biodesix's commitment to a people-first culture that fosters trust, collaboration, and accountability, supporting its mission to i…
ConnectOne Bancorp, Inc. announced it will release its first quarter 2026 financial results prior to market open on April 23, 2026, followed by a conference call led by its CEO and CFO. The call will discuss the company's financial performance and operating results, and it will be accessible to investors via webcast and replay.
